Novo Nordisk

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.

About NVO

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments.

CEO

Maziar Mike Doustdar

CEOMaziar Mike Doustdar

Employees

68,794

Employees68,794

Headquarters

Bagsværd, Capital Region

HeadquartersBagsværd, Capital Region

Founded

1923

Founded1923

Employees

68,794

Employees68,794

NVO Key Statistics

Market cap

189.60B

Market cap189.60B

Price-Earnings ratio

9.81

Price-Earnings ratio9.81

Dividend yield

3.06%

Dividend yield3.06%

Average volume

11.91M

Average volume11.91M

High today

$41.60

High today$41.60

Low today

$41.36

Low today$41.36

Open price

$42.43

Open price$42.43

Volume

495.61K

Volume495.61K

52 Week high

$64.16

52 Week high$64.16

52 Week low

$35.12

52 Week low$35.12

NVO News

Investing.com 57m

Citi raises Novo Nordisk stock target despite ’mixed’ results - Investing.com

...

The Motley Fool 11h

Novo Nordisk: 3 Key Takeaways for Long-Term Investors

On its third-quarter 2026 earnings call, held on Nov. 4, 2026, Novo Nordisk (NVO +4.95%) announced raised full-year financial guidance alongside a return to vol...

The Wall Street Journal 15h

Novo Nordisk Stock Jumps After Outlook Improves

Novo Nordisk’s U.S.-traded shares were up nearly 5% Wednesday, their largest increase since June, after the Danish drugmaker improved its sales outlook. The co...

Analyst ratings

50%

of 6 ratings

Buy

16.7%

Hold

50%

Sell

33.3%

More NVO News

The Motley Fool 16h

Novo Nordisk Stock Jumped After Earnings — But Its CEO Won't Give 2027 Guidance. Here's What Investors Should Know

Novo Nordisk (NVO +5.24%) gave investors a lot of what they wanted on Wednesday. Third-quarter sales rose 4% at constant exchange rates to about $11.9 billion,...

Benzinga 23h

Novo Nordisk Raises 2026 Outlook As Wegovy Pill Shines

Novo Nordisk A/S (NYSE:NVO) stock rose Wednesday after the drugmaker reported better-than-expected third-quarter earnings and raised its full-year outlook. Nov...

Simply Wall St 23h

Is Novo Nordisk Reasonable After Its 58% Fall?

has seen its share price fall sharply in recent years, even as attention stays fixed on its diabetes and obesity franchise. With the stock down heavily over a 3...

The Motley Fool 1d

Viking Therapeutics Trades 23% Below Its Own $35 Secondary Offering Price. Here's Why That Could Be a Gift for Patient Investors.

Viking Therapeutics (VKTX -2.76%) has been a company to watch over the past few years. That's because the biotech is involved in one of the healthcare market's...

The Wall Street Journal 1d

Health Care Roundup: Market Talk

Yves Herman / Reuters The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET....

The Motley Fool 4d

Novo Nordisk Trades at 10 Times Earnings While Buying Back Billions in Stock. Is This the Bottom?

Shares of Novo Nordisk (NVO +2.20%) have declined roughly 70% from their 2024 high. The stock is now below its level in mid-2021, when it first introduced the W...

Simply Wall St 6d

Novo Nordisk Could Be 62% Undervalued On GLP 1 Growth Expectations

Advertisement Recent Share Performance and Business Profile Novo Nordisk (NYSE:NVO) has been trading around US$39.14 per share, with the price moving higher o...

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.